NovaPharm Healthcare Insightshttps://novapharmhealthcare.com/news-insights/Regulatory, quality, oncology, supply-chain and technology perspectives from NovaPharm Healthcare.en-gbBuilding a Compliance-First Pharmaceutical Distribution Model in the UKhttps://novapharmhealthcare.com/news-insights/compliance-first-pharmaceutical-distribution-uk/https://novapharmhealthcare.com/news-insights/compliance-first-pharmaceutical-distribution-uk/Sat, 11 Jul 2026 12:00:00 GMTA practical framework for designing a UK pharmaceutical distribution business in which authorisation, quality governance and commercial operations develop in the right order.RegulatoryFrom Batch to Buyer: Designing More Traceable Pharmaceutical Supply Chainshttps://novapharmhealthcare.com/news-insights/batch-to-buyer-pharmaceutical-traceability/https://novapharmhealthcare.com/news-insights/batch-to-buyer-pharmaceutical-traceability/Sat, 11 Jul 2026 12:00:00 GMTA practical architecture for connecting product, batch, temperature, custody, order, customer and quality records without overstating blockchain or automation maturity.TechnologyGDP, QMS and the Practical Foundations of Reliable Pharmaceutical Distributionhttps://novapharmhealthcare.com/news-insights/gdp-qms-pharmaceutical-distribution-foundations/https://novapharmhealthcare.com/news-insights/gdp-qms-pharmaceutical-distribution-foundations/Sat, 11 Jul 2026 12:00:00 GMTHow Good Distribution Practice and a proportionate Quality Management System turn pharmaceutical policies into controlled, reviewable daily operations.QualityThree-Pillar Sourcing: Direct GMP Partnerships, PLPI and European Buying Networkshttps://novapharmhealthcare.com/news-insights/three-pillar-pharmaceutical-sourcing-model/https://novapharmhealthcare.com/news-insights/three-pillar-pharmaceutical-sourcing-model/Sat, 11 Jul 2026 12:00:00 GMTHow three distinct pharmaceutical sourcing channels can be governed as one portfolio to improve optionality without weakening quality or regulatory discipline.Supply chainWhat PLPI Means for Pharmaceutical Supply Resilience and Cost-Optimised Accesshttps://novapharmhealthcare.com/news-insights/plpi-pharmaceutical-supply-resilience/https://novapharmhealthcare.com/news-insights/plpi-pharmaceutical-supply-resilience/Sat, 11 Jul 2026 12:00:00 GMTAn evidence-led explanation of the UK parallel-import route, its operational requirements and the role it may play within a diversified pharmaceutical sourcing strategy.Market accessWhy Oncology Supply Chains Require Specialised Demand Forecastinghttps://novapharmhealthcare.com/news-insights/oncology-supply-chain-demand-forecasting/https://novapharmhealthcare.com/news-insights/oncology-supply-chain-demand-forecasting/Sat, 11 Jul 2026 12:00:00 GMTWhy oncology demand is difficult to predict, which data and controls matter, and how a governed forecasting roadmap should support rather than replace pharmaceutical judgement.Oncology